Compassionate use of pergolide as adjunctive therapy to levodopa/carbidopa for treating Parkinson's Disease.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2012
At a glance
- Drugs Pergolide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Valeant Pharmaceuticals International
- 23 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Mar 2008 New trial record.